Cedars-Sinai Neuro Experts Share Findings at Alzheimer’s Conference

Cedars-Sinai physician-scientists will join peers from around the world at the Alzheimer's Association International Conference July 27-31 in Toronto. The much-anticipated meeting often yields breaking news about potential new diagnostic tools and treatments in development for the neurodegenerative disease.

Cedars-Sinai experts attending the conference and available for interviews include:

Mitzi Gonzales, PhD , director of Translational Research in the Jona Goldrich Center for Alzheimer's and Memory Disorders and associate professor of Neurology, will present data linking retinal amyloid imaging to cognition and hippocampal integrity from a study conducted with Maya Koronyo-Hamaoui, PhD. Gonzales leads research programs aimed at discovering mechanisms underlying neurodegenerative diseases and developing targeted interventions to preserve cognition across patients' lifespans.

Maya Koronyo-Hamaoui, PhD , professor of Neurosurgery, Neurology, and Biomedical Sciences, can discuss her lab's research being presented at the conference on connections between synaptic loss, vascular dysfunction, degradation of neurons and amyloid buildup in the retina as well as symptoms and brain changes associated with Alzheimer's disease.

Sarah Kremen, MD , director of the Neurobehavior Program and associate professor of Neurology, treats patients with memory, language and other cognitive disorders due to Alzheimer's and related neurodegenerative diseases. She also leads the Goldrich Center Alzheimer's Disease and Related Disorders clinical trial program.

Zaldy Tan, MD, MPH , director of the Memory and Healthy Aging Program, medical director of the Jona Goldrich Center for Alzheimer's and Memory Disorders and professor of Neurology, will present abstracts on modifiable risk factors in people at risk for Alzheimer's disease and screening tools to identify people with cognitive impairment upon hospital admission.

Golnaz Yadollahikhales, MD , assistant professor of Neurology and co-director of the Neurobehavior Fellowship Program, can discuss research focused on biomarker development and early diagnosis of neurodegenerative disorders.

To arrange an interview, contact Christina Elston at [email protected] or call/text 626-298-0702.

Cedars-Sinai Health Sciences University is advancing groundbreaking research and educating future leaders in medicine, biomedical sciences and allied health sciences. Learn more about the university.